Cargando…
Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India
Background: Patients with first-line drug resistance (DR) to rifampicin (RIF) or isoniazid (INH) as a first-line (FL) line probe assay (LPA) were subjected to genotypic DST using second-line (SL) LPA to identify SL-DR (including pre-XDR) under the National TB Elimination Program (NTEP), India. SL-DR...
Autores principales: | Gopalaswamy, Radha, Palani, Nandhini, Viswanathan, Dinesh, Preysingh, Bershila, Rajendran, Suchithra, Vijayaraghavan, Vaishnavee, Thangavel, Kannadasan, Vadivel, Senthil Devi, Stanley, Hannah, Thiruvengadam, Kannan, Jayabal, Lavanya, Murugesan, Kaleeswari, Rathinam, Sridhar, Frederick, Asha, Sivaramakrishnan, Gomathi, Padmapriyadarsini, Chandrasekaran, Shanmugam, Sivakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303903/ https://www.ncbi.nlm.nih.gov/pubmed/37374209 http://dx.doi.org/10.3390/medicina59061005 |
Ejemplares similares
-
Drug susceptibility profiling of pulmonary Mycobacterium kansasii and its correlation with treatment outcome
por: Rajendran, Priya, et al.
Publicado: (2021) -
Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India
por: Velayutham, Banurekha, et al.
Publicado: (2023) -
An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India
por: Krishnan, Rajendran, et al.
Publicado: (2022) -
Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease
por: Velayutham, Banurekha, et al.
Publicado: (2023) -
Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment
por: Gopalaswamy, Radha, et al.
Publicado: (2020)